Skip to main content
New Year’s Sale — Build a balanced news diet with 40% off Vantage
Get Started
SubscribeLogin
Published • loading... • Updated

Biotech’s groove is back for 2026 as XBI surges on M&A and lower rates

Summary by endpoints.news
Biotech executives and shareholders can breathe easier heading into the new year for the first time in nearly half a decade. The industry’s leaders will arrive at January’s JP Morgan Healthcare Conference riding a surge ...
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.Cross Cancel Icon

1 Articles

endpoints.newsendpoints.news

Biotech’s groove is back for 2026 as XBI surges on M&A and lower rates

Biotech executives and shareholders can breathe easier heading into the new year for the first time in nearly half a decade. The industry’s leaders will arrive at January’s JP Morgan Healthcare Conference riding a surge ...

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

endpoints.news broke the news in on Tuesday, December 30, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Biotech icon

Biotech

Mergers & Acquisitions icon

Mergers & Acquisitions

San Francisco, California icon

San Francisco, California

Health & Medicine icon

Health & Medicine

Business & Markets icon

Business & Markets

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal